 "Pharma exporters hope for a barter-deal with African nations to beat currency blues")
After registering a de-growth of 17 per cent during 2015-16 to Rs 506 crore, Ahmedabad-headquartered drug major Torrent Pharma has managed to turn around its Brazilian business, where it is the largest Indian generics player. This year in the first nine months it has grown by 25 per cent, recording revenues of Rs 484 crore.
During the third quarter, the company's Brazil business recorded a growth of 35 per cent on a year on year (yoy) basis to Rs 159 crore. A company spokesperson explained that the devaluation of the Brazilian currency (Real) owing to political and economic turmoil in
